Cancer Research - Plato Data Intelligence

NCI study challenges long-held beliefs about cell division

Clinical TrialsJuly 5, 2023

What A new study suggests that cells preparing to divide can reverse this process and return...

New on NCI’s Websites for June 2023

Clinical TrialsJune 29, 2023

June 29, 2023, by Daryl McGrath NCI’s collection of cancer information products is constantly...

The promise of immunotherapy for autoimmune diseases

BiotechnologyJune 27, 2023

Our immune system serves as the body’s chief line of defense against harmful invaders. But what happens when this mighty defense mechanism turns on...

Pancreatic Cancer Finds Alternate Fuel for Survival, Growth

Clinical TrialsJune 22, 2023

June 22, 2023, by Carmen Phillips Like a sidecar on a motorcycle, a sugar molecule called ribose...

Metformin’s role in preventing metabolic syndrome during androgen

BiotechnologyJune 20, 2023

“ we found no impact of the addition of metformin to therapy on risk of metabolic syndrome associated with castration therapy and no...

ASCO showcased the payoff for new cancer medicines: longer lives

BiotechnologyJune 7, 2023

CHICAGO — Well, that’s a wrap. The biggest meeting in cancer research — and, really, one of the biggest annual conferences for the pharmaceutical...

Closing ASCO: AstraZeneca’s ‘very special’ meeting, more CAR-T survival data and Pfizer’s PARP play

BiotechnologyJune 6, 2023

Pascal Soriot has been attending the American Society of Clinical Oncology’s annual meeting for the past two decades. This year’s conference, the AstraZeneca CEO told...

ComboMATCH will test new combinations of cancer drugs

Clinical TrialsJune 1, 2023

The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the...

A novel blood serum assay to diagnose neurodegenerative diseases

BiotechnologyMay 29, 2023

Synucleinopathies are a group of neurodegenerative diseases caused by the abnormal accumulation α-synuclein, a protein normally found in the brain and neurons. Incorrect folding...

UCSD to test cancer drugs in space using private astronaut mission

Nano TechnologyMay 25, 2023

UCSD to test cancer drugs in space using private astronaut mission by Staff Writers San Diego CA (SPX) May 24, 2023 On...

Artificial Intelligence (AI) has the ability to predict pancreatic cancer three years in advance compared to human doctors, according to a recent study.

ZephyrnetMay 9, 2023

Artificial Intelligence (AI) has been making waves in the medical industry for quite some time now. From diagnosing diseases to predicting outcomes, AI has...